Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1292 Views
-
Last post by frodo
-
- 0 Replies
- 956 Views
-
Last post by frodo
-
- 0 Replies
- 2298 Views
-
Last post by NHE
-
- 0 Replies
- 1265 Views
-
Last post by frodo
-
- 0 Replies
- 1221 Views
-
Last post by frodo
-
- 0 Replies
- 1178 Views
-
Last post by frodo
-
- 0 Replies
- 1431 Views
-
Last post by NHE
-
- 0 Replies
- 468 Views
-
Last post by NHE
-
- 1 Replies
- 2905 Views
-
Last post by Tif